{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:52:14Z","timestamp":1790376734401,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.gene.2017.07.068","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T23:01:45Z","timestamp":1501110105000},"page":"117-126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Association of clinical severity of cystic fibrosis with variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1 and SLC9A3)"],"prefix":"10.1016","volume":"629","author":[{"given":"St\u00e9phanie Villa-Nova","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Dirceu","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen S\u00edlvia","family":"Bertuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Augusto Lima","family":"Marson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2017.07.068_bb0005","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1113\/jphysiol.2008.154500","article-title":"Human solute carrier SLC6A14 is the \u03b2-alanine carrier","volume":"586","author":"Anderson","year":"2008","journal-title":"J. Physiol."},{"key":"10.1016\/j.gene.2017.07.068_bb0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/gene.2015.8","article-title":"Genetic variants of SLC11A1 are associated with both autoimmune and infectious diseases: systematic review and meta-analysis","volume":"16","author":"Archer","year":"2015","journal-title":"Genes Immun."},{"key":"10.1016\/j.gene.2017.07.068_bb0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1085\/jgp.200810097","article-title":"SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia","volume":"133","author":"Bertrand","year":"2009","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.gene.2017.07.068_bb0020","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2337\/db13-0510","article-title":"Genetic modifiers of cystic fibrosis-related diabetes","volume":"62","author":"Blackman","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.gene.2017.07.068_bb0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.gene.2014.02.040","article-title":"CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease","volume":"540","author":"Bonadia","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.gene.2017.07.068_bb0030","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nsmb.1854","article-title":"Ion\/substrate-dependent conformational dynamics of a bacterial homolog of neurotransmitter: sodium symporters","volume":"17","author":"Claxton","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.gene.2017.07.068_bb0035","first-page":"87","article-title":"TNF-alpha polymorphisms as a potential modifier gene in the cystic fibrosis","volume":"5","author":"Coutinho","year":"2014","journal-title":"Int. J. Mol. Epidemiol. Genet."},{"key":"10.1016\/j.gene.2017.07.068_bb0040","author":"Dean"},{"key":"10.1016\/j.gene.2017.07.068_bb0045","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1113\/jphysiol.2007.135855","article-title":"SLC26A9 is a Cl(-) channel regulated by the WNK kinases","volume":"584","author":"Dorwart","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.gene.2017.07.068_bb0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/1756-0500-5-561","article-title":"Association between the IVS4G>T mutation in the TCF7L2 gene and susceptibility to diabetes in cystic fibrosis patients","volume":"5","author":"Furgeri","year":"2012","journal-title":"BMC. Res. Notes"},{"key":"10.1016\/j.gene.2017.07.068_bb0055","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00439-016-1684-4","article-title":"IL8 gene as modifier of cystic fibrosis: unraveling the factors which influence clinical variability","volume":"135","author":"Furlan","year":"2016","journal-title":"Hum. Genet."},{"key":"10.1016\/j.gene.2017.07.068_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jped.2017.03.005","article-title":"Variants in the IL-8 gene and the response to inhaled bronchodilators in cystic fibrosis","author":"Furlan","year":"2017","journal-title":"J. Pediatr."},{"key":"10.1016\/j.gene.2017.07.068_bb0065","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/TACG.S18675","article-title":"Disease-modifying genes and monogenic disorders: experience in cystic fibrosis","volume":"7","author":"Gallati","year":"2014","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.gene.2017.07.068_bb0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jcf.2011.01.005","article-title":"Association between genotype and pulmonary phenotype in cystic fibrosis patients with severe mutations","volume":"10","author":"Geborek","year":"2011","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.gene.2017.07.068_bb0075","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1074\/jbc.M306092200","article-title":"Identification of an additional interaction domain in transmembrane domains 11 and 12 that supports oligomer formation in the human serotonin transporter","volume":"279","author":"Just","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2017.07.068_bb0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.bioeng.9.060906.152037","article-title":"SNP genotyping: technologies and biomedical applications","volume":"9","author":"Kim","year":"2007","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.gene.2017.07.068_bb0085","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature10737","article-title":"X-ray structures of LeuT in substrate-free outward-open and apo inward-open states","volume":"481","author":"Krishnamurthy","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.gene.2017.07.068_bb0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00439-013-1363-7","article-title":"Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities","volume":"133","author":"Li","year":"2014","journal-title":"Hum. Genet."},{"key":"10.1016\/j.gene.2017.07.068_bb0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1590\/S1806-37132012000100008","article-title":"CFTR mutations and GSTM1 and GSTT1 deletions in Brazilian cystic fibrosis patients","volume":"38","author":"Lima","year":"2012","journal-title":"J. Bras. Pneumol."},{"key":"10.1016\/j.gene.2017.07.068_bb0100","first-page":"1","article-title":"The ACE gene D\/I polymorphism as a modulator of severity of cystic fibrosis","volume":"12","author":"Marson","year":"2012","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.gene.2017.07.068_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2466-12-50","article-title":"Polymorphisms in ADRB2 gene can modulate the response to bronchodilators and the severity of cystic fibrosis","volume":"12","author":"Marson","year":"2012","journal-title":"BMC Pulm. Med."},{"key":"10.1016\/j.gene.2017.07.068_bb0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2350-14-60","article-title":"Genetic interaction of GSH metabolic pathway genes in cystic fibrosis","volume":"14","author":"Marson","year":"2013","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.gene.2017.07.068_bb0115","first-page":"1000058","article-title":"The IFRD1 (57460C>T polymorphism) gene: a negative report in cystic fibrosis clinical severity","volume":"7","author":"Marson","year":"2013","journal-title":"J. Mol. Genet. Med."},{"key":"10.1016\/j.gene.2017.07.068_bb0120","doi-asserted-by":"crossref","first-page":"132","DOI":"10.9735\/0975-2862.5.1.132-138","article-title":"COX-2 gene polymorphisms: genetic determinants of cystic fibrosis comorbidities","volume":"5","author":"Marson","year":"2013","journal-title":"Int. J. Genet."},{"key":"10.1016\/j.gene.2017.07.068_bb0125","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2350-15-27","article-title":"Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study","volume":"15","author":"Marson","year":"2014","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.gene.2017.07.068_bb0130","first-page":"246","article-title":"ADIPOR2 polymorphisms in cystic fibrosis are potential modifiers of clinical severity","volume":"5","author":"Marson","year":"2014","journal-title":"J. Genet. Syndr. Gene Ther."},{"key":"10.1016\/j.gene.2017.07.068_bb0135","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2174\/1389450115666141128121118","article-title":"Personalized drug therapy in cystic fibrosis: from fiction to reality","volume":"16","author":"Marson","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.gene.2017.07.068_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2017.00390","article-title":"Personalized or precision medicine? The example of cystic fibrosis","author":"Marson","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.gene.2017.07.068_bb0145","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jpeds.2015.01.044","article-title":"Variants in solute carrier SLC26A9 modify prenatal exocrine pancreatic damage in cystic fibrosis","volume":"166","author":"Miller","year":"2015","journal-title":"J. Pediatr."},{"key":"10.1016\/j.gene.2017.07.068_bb0150","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1136\/gut.36.2.215","article-title":"Chloride-dependence of amino acid transport in rabbit ileum","volume":"36","author":"Munk","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.gene.2017.07.068_bb0155","author":"National Center for Biotechnology Information - NCBI"},{"key":"10.1016\/j.gene.2017.07.068_bb0160","author":"Online Mendelian Inheritance in Man - OMIN"},{"key":"10.1016\/j.gene.2017.07.068_bb0165","author":"Online Mendelian Inheritance in Man - OMIN"},{"key":"10.1016\/j.gene.2017.07.068_bb0170","first-page":"L795","article-title":"Role of lung iron in determining the bacterial and host struggle in cystic fibrosis","volume":"297","author":"Reid","year":"2009","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.gene.2017.07.068_bb0175","doi-asserted-by":"crossref","first-page":"125","DOI":"10.9735\/0975-2862.5.1.125-131","article-title":"ADRA2A is a cystic fibrosis modifier gene","volume":"5","author":"Rezende","year":"2013","journal-title":"Int. J. Genet."},{"key":"10.1016\/j.gene.2017.07.068_bb0180","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/aje\/kwn359","article-title":"Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies","volume":"169","author":"Rodriguez","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.gene.2017.07.068_bb0185","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1590\/S1806-37132004000300016","article-title":"Critical analysis of scoring systems used in the assessment of cystic fibrosis severity: state of the art","volume":"30","author":"Santos","year":"2004","journal-title":"J. Bras. Pneumol."},{"key":"10.1016\/j.gene.2017.07.068_bb0190","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.humimm.2012.02.008","article-title":"Association of SLC11A1 (NRAMP1) polymorphisms with pulmonar Mycobacterium avium complex infection","volume":"73","author":"Sapkota","year":"2012","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.gene.2017.07.068_bb0195","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.2337\/db13-1464","article-title":"Evidence for a causal relationship between early exocrine pancreatic disease and cystic fibrosis-related diabetes: a Mendelian randomization study","volume":"63","author":"Soave","year":"2014","journal-title":"Diabetes"},{"issue":"20","key":"10.1016\/j.gene.2017.07.068_bb0200","first-page":"4590","article-title":"Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics","volume":"25","author":"Strug","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.gene.2017.07.068_bb0205","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ng.2221","article-title":"Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis","volume":"44","author":"Sun","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2017.07.068_bb0215","doi-asserted-by":"crossref","first-page":"15649","DOI":"10.1074\/jbc.M410858200","article-title":"p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process","volume":"280","author":"Zhu","year":"2005","journal-title":"J. Biol. Chem."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111917306030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111917306030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T09:39:26Z","timestamp":1656581966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111917306030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":42,"alternative-id":["S0378111917306030"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2017.07.068","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of clinical severity of cystic fibrosis with variants in the SLC gene family (SLC6A14, SLC26A9, SLC11A1 and SLC9A3)","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2017.07.068","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}